skip to main content
Language:
Search Limited to: Search Limited to: Resource type Show Results with: Show Results with: Search type Index

Results 21 - 40 of 710,245  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page
Show only
Result Number Material Type Add to My Shelf Action Record Details and Options
21
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants
Material Type:
Article 		Add to My Research

Cross-neutralizing antibodies bind a SARS-CoV-2 cryptic site and resist circulating variants

Nature communications, 2021-09, Vol.12 (1), p.5652-5652, Article 5652 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-25997-3 ;PMID: 34580306

Full text available

Citations Cited by
22
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Material Type:
Article 		Add to My Research

A perspective on potential antibody-dependent enhancement of SARS-CoV-2

Nature (London), 2020-08, Vol.584 (7821), p.353-363 [Peer Reviewed Journal]

COPYRIGHT 2020 Nature Publishing Group ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-020-2538-8 ;PMID: 32659783

Full text available

Citations Cited by
23
Preparing for the Future — Nanobodies for Covid-19?
Preparing for the Future — Nanobodies for Covid-19?
Material Type:
Article 		Add to My Research

Preparing for the Future — Nanobodies for Covid-19?

New England Journal of Medicine, 2021-04, Vol.384 (16), p.1568-1571 [Peer Reviewed Journal]

Copyright © 2021 Massachusetts Medical Society. All rights reserved. ;COPYRIGHT 2021 Massachusetts Medical Society ;2021. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.nejm.org/about-nejm/permissions?query=footer ;ISSN: 0028-4793 ;EISSN: 1533-4406 ;DOI: 10.1056/NEJMcibr2101205 ;PMID: 33826817

Digital Resources/Online E-Resources

Citations Cited by
24
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV
Material Type:
Article 		Add to My Research

B cell genomics behind cross-neutralization of SARS-CoV-2 variants and SARS-CoV

Cell, 2021-06, Vol.184 (12), p.3205-3221.e24 [Peer Reviewed Journal]

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021 Elsevier Inc. 2021 Elsevier Inc. ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2021.04.032 ;PMID: 34015271

Full text available

Citations Cited by
25
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes
Material Type:
Article 		Add to My Research

Potent neutralizing nanobodies resist convergent circulating variants of SARS-CoV-2 by targeting diverse and conserved epitopes

Nature communications, 2021-08, Vol.12 (1), p.4676-4676, Article 4676 [Peer Reviewed Journal]

2021. The Author(s). ;The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-021-24963-3 ;PMID: 34344900

Full text available

Citations Cited by
26
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells
Material Type:
Article 		Add to My Research

Potent Neutralizing Antibodies against SARS-CoV-2 Identified by High-Throughput Single-Cell Sequencing of Convalescent Patients’ B Cells

Cell, 2020-07, Vol.182 (1), p.73-84.e16 [Peer Reviewed Journal]

2020 ;Copyright © 2020. Published by Elsevier Inc. ;2020. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2020 Published by Elsevier Inc. 2020 ;ISSN: 0092-8674 ;EISSN: 1097-4172 ;DOI: 10.1016/j.cell.2020.05.025 ;PMID: 32425270

Digital Resources/Online E-Resources

Citations Cited by
27
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus
Material Type:
Article 		Add to My Research

Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus

Nature (London), 2013-04, Vol.496 (7446), p.469-476 [Peer Reviewed Journal]

COPYRIGHT 2013 Nature Publishing Group ;COPYRIGHT 2013 Nature Publishing Group ;Copyright Nature Publishing Group Apr 25, 2013 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/nature12053 ;PMID: 23552890 ;CODEN: NATUAS

Full text available

Citations Cited by
28
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization
Material Type:
Article 		Add to My Research

Analysis of a Therapeutic Antibody Cocktail Reveals Determinants for Cooperative and Broad Ebolavirus Neutralization

Immunity (Cambridge, Mass.), 2020-02, Vol.52 (2), p.388-403.e12 [Peer Reviewed Journal]

2020 Elsevier Inc. ;Copyright © 2020 Elsevier Inc. All rights reserved. ;2020. Elsevier Inc. ;2020 Elsevier Inc. 2020 Elsevier Inc. ;ISSN: 1074-7613 ;EISSN: 1097-4180 ;DOI: 10.1016/j.immuni.2020.01.001 ;PMID: 32023489

Full text available

Citations Cited by
29
Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation
Material Type:
Article 		Add to My Research

Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulation

Immunological reviews, 2016-03, Vol.270 (1), p.132-151 [Peer Reviewed Journal]

2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd ;2016 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd. ;ISSN: 0105-2896 ;EISSN: 1600-065X ;DOI: 10.1111/imr.12392 ;PMID: 26864109

Full text available

Citations Cited by
30
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants
Material Type:
Article 		Add to My Research

LY-CoV1404 (bebtelovimab) potently neutralizes SARS-CoV-2 variants

Cell Reports, 2022-05, Vol.39 (7), p.110812-110812, Article 110812 [Peer Reviewed Journal]

2022 The Authors ;Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved. ;2022. Not withstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://www.elsevier.com/legal/elsevier-website-terms-and-conditions ;2022 The Authors 2022 ;ISSN: 2211-1247 ;EISSN: 2211-1247 ;DOI: 10.1016/j.celrep.2022.110812 ;PMID: 35568025

Digital Resources/Online E-Resources

Citations Cited by
31
Broad sarbecovirus neutralization by a human monoclonal antibody
Broad sarbecovirus neutralization by a human monoclonal antibody
Material Type:
Article 		Add to My Research

Broad sarbecovirus neutralization by a human monoclonal antibody

Nature (London), 2021-09, Vol.597 (7874), p.103-108 [Peer Reviewed Journal]

2021. The Author(s), under exclusive licence to Springer Nature Limited. ;Copyright Nature Publishing Group Sep 2, 2021 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-021-03817-4 ;PMID: 34280951

Full text available

Citations Cited by
32
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies
Material Type:
Article 		Add to My Research

Targeting SARS-CoV2 Spike Protein Receptor Binding Domain by Therapeutic Antibodies

Biomedicine & pharmacotherapy, 2020-10, Vol.130, p.110559-110559, Article 110559 [Peer Reviewed Journal]

2020 The Authors ;Copyright © 2020 The Authors. Published by Elsevier Masson SAS.. All rights reserved. ;2020 The Authors 2020 ;ISSN: 0753-3322 ;EISSN: 1950-6007 ;DOI: 10.1016/j.biopha.2020.110559 ;PMID: 32768882

Full text available

Citations Cited by
33
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection
Material Type:
Article 		Add to My Research

Generation and Characterization of ALX-0171, a Potent Novel Therapeutic Nanobody for the Treatment of Respiratory Syncytial Virus Infection

Antimicrobial agents and chemotherapy, 2016-01, Vol.60 (1), p.6-13 [Peer Reviewed Journal]

Copyright © 2015 Detalle et al. ;Copyright © 2015 Detalle et al. 2015 Detalle et al. ;ISSN: 0066-4804 ;EISSN: 1098-6596 ;DOI: 10.1128/aac.01802-15 ;PMID: 26438495

Full text available

Citations Cited by
34
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability
Material Type:
Article 		Add to My Research

Potent neutralizing antibodies from COVID-19 patients define multiple targets of vulnerability

Science, 2020-08, Vol.369 (6504) [Peer Reviewed Journal]

2020. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;DOI: 10.1126/science.abc5902

Digital Resources/Online E-Resources

Citations Cited by
35
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection
Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection
Material Type:
Article 		Add to My Research

Multi-Donor Longitudinal Antibody Repertoire Sequencing Reveals the Existence of Public Antibody Clonotypes in HIV-1 Infection

Cell host & microbe, 2018-06, Vol.23 (6), p.845-854.e6 [Peer Reviewed Journal]

2018 The Authors ;Copyright © 2018 The Authors. Published by Elsevier Inc. All rights reserved. ;2018 The Authors 2018 ;ISSN: 1931-3128 ;EISSN: 1934-6069 ;DOI: 10.1016/j.chom.2018.05.001 ;PMID: 29861170

Full text available

Citations Cited by
36
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants
Material Type:
Article 		Add to My Research

Memory B cell repertoire from triple vaccinees against diverse SARS-CoV-2 variants

Nature (London), 2022-03, Vol.603 (7903), p.919-925 [Peer Reviewed Journal]

2022. The Author(s). ;Copyright Nature Publishing Group Mar 31, 2022 ;The Author(s) 2022 ;ISSN: 0028-0836 ;EISSN: 1476-4687 ;DOI: 10.1038/s41586-022-04466-x ;PMID: 35090164

Full text available

Citations Cited by
37
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies
Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies
Material Type:
Article 		Add to My Research

Structural basis for accommodation of emerging B.1.351 and B.1.1.7 variants by two potent SARS-CoV-2 neutralizing antibodies

Structure (London), 2021-07, Vol.29 (7), p.655-663.e4 [Peer Reviewed Journal]

2021 ;Copyright © 2021. Published by Elsevier Ltd. ;2021 Published by Elsevier Ltd. 2021 ;ISSN: 0969-2126 ;EISSN: 1878-4186 ;DOI: 10.1016/j.str.2021.05.014 ;PMID: 34111408

Full text available

Citations Cited by
38
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity
Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity
Material Type:
Article 		Add to My Research

Rational design of a trispecific antibody targeting the HIV-1 Env with elevated anti-viral activity

Nature communications, 2018-02, Vol.9 (1), p.877-12, Article 877 [Peer Reviewed Journal]

2018. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2018 ;ISSN: 2041-1723 ;EISSN: 2041-1723 ;DOI: 10.1038/s41467-018-03335-4 ;PMID: 29491415

Full text available

Citations Cited by
39
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody
Material Type:
Article 		Add to My Research

Structural insights of a highly potent pan-neutralizing SARS-CoV-2 human monoclonal antibody

Proceedings of the National Academy of Sciences - PNAS, 2022-05, Vol.119 (20), p.e2120976119-e2120976119 [Peer Reviewed Journal]

Copyright National Academy of Sciences May 17, 2022 ;Attribution ;Copyright © 2022 the Author(s). Published by PNAS. 2022 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.2120976119 ;PMID: 35549549

Full text available

Citations Cited by
40
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo
Material Type:
Article 		Add to My Research

Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo

Proceedings of the National Academy of Sciences - PNAS, 2012-11, Vol.109 (46), p.18921-18925 [Peer Reviewed Journal]

copyright © 1993-2008 National Academy of Sciences of the United States of America ;Copyright National Academy of Sciences Nov 13, 2012 ;ISSN: 0027-8424 ;EISSN: 1091-6490 ;DOI: 10.1073/pnas.1214785109 ;PMID: 23100539

Full text available

Citations Cited by

Results 21 - 40 of 710,245  for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method
previous page 1 Results 2 3 4 5 next page

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Show only

  1. Peer-reviewed Journals (638,772)

Refine My Results

Creation Date 

From To
Refine
  1. Before 1961  (4,263)
  2. 1961 To 1976  (40,477)
  3. 1977 To 1992  (136,146)
  4. 1993 To 2009  (214,116)
  5. After 2009  (315,494)
  6. More options open sub menu

Subject 

  1. Science & Technology  (547,211)
  2. Life Sciences & Biomedicine  (501,673)
  3. Humans  (358,292)
  4. Animals  (272,661)
  5. Antibodies  (195,273)
  6. Female  (179,246)
  7. Biological And Medical Sciences  (174,964)
  8. Male  (152,079)
  9. Immunology  (137,721)
  10. Mice  (124,864)
  11. Fundamental And Applied Biological Sciences. Psychology  (97,162)
  12. Adult  (90,460)
  13. Medical Sciences  (90,132)
  14. Proteins  (82,211)
  15. Monoclonal Antibodies  (79,951)
  16. Middle Aged  (77,757)
  17. Microbiology  (71,416)
  18. Infectious Diseases  (64,843)
  19. Fluorescent Antibody Technique  (62,997)
  20. Antigens  (60,425)
  21. More options open sub menu

Language 

  1. English  (698,061)
  2. Japanese  (91,825)
  3. Portuguese  (3,938)
  4. French  (3,479)
  5. German  (3,024)
  6. Spanish  (2,758)
  7. Russian  (1,259)
  8. Chinese  (625)
  9. Korean  (521)
  10. Polish  (387)
  11. Norwegian  (385)
  12. Italian  (374)
  13. Turkish  (297)
  14. Persian  (116)
  15. Swedish  (102)
  16. Czech  (100)
  17. Croatian  (68)
  18. Serbian  (48)
  19. Slovak  (36)
  20. Dutch  (29)
  21. More options open sub menu
INSPIRE LIBRARY - TON DUC THANG UNIVERSITY (84-028) 37 755 057 Feedback
19 Nguyen Huu Tho St. Dist.7, HCM thuvien@tdtu.edu.vn

Copyright © 2017 INSPIRE LIBRARY - TON DUC THANG UNIVERSITY

Searching Remote Databases, Please Wait